MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s13058-023-01603-w

Медицинская библиотека · Breast cancer research : BCR · 2023

Multimorbidity and overall survival among women with breast cancer: results from the South African Breast Cancer and HIV Outcomes Study.

Ayeni Oluwatosin A, Joffe Maureen, Mapanga Witness, Chen Wenlong Carl, O'Neil Daniel S, Phakathi Boitumelo, Nietz Sarah, Buccimazza Ines, Čačala Sharon, Stopforth Laura W, Jacobson Judith S, Crew Katherine D, Neugut Alfred I, Ramiah Duvern, Ruff Paul, Cubasch Herbert, Chirwa Tobias, McCormack Valerie, Micklesfield Lisa K, Norris Shane A

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Breast cancer survival in South Africa is low, but when diagnosed with breast cancer, many women in South Africa also have other chronic conditions. We investigated the impact of multimorbidity (≥ 2 other chronic conditions) on overall survival among women with breast cancer in South Africa.

METHODS

Between 1 July 2015 and 31 December 2019, we enrolled women newly diagnosed with breast cancer at six public hospitals participating in the South African Breast Cancer and HIV Outcomes (SABCHO) Study. We examined seven chronic conditions (obesity, hypertension, diabetes, HIV, cerebrovascular diseases (CVD), asthma/chronic obstructive pulmonary disease, and tuberculosis), and we compared socio-demographic, clinical, and treatment factors between patients with and without each condition, and with and without multimorbidity. We investigated the association of multimorbidity with overall survival using multivariable Cox proportional hazard models.

RESULTS

Of 3,261 women included in the analysis, 45% had multimorbidity; obesity (53%), hypertension (41%), HIV (22%), and diabetes (13%) were the most common individual conditions. Women with multimorbidity had poorer overall survival at 3 years than women without multimorbidity in both the full cohort (60.8% vs. 64.3%, p = 0.036) and stage groups: stages I-II, 80.7% vs. 86.3% (p = 0.005), and stage III, 53.0% vs. 59.4% (p = 0.024). In an adjusted model, women with diabetes (hazard ratio (HR) = 1.20, 95% confidence interval (CI) = 1.03-1.41), CVD (HR = 1.43, 95% CI = 1.17-1.76), HIV (HR = 1.21, 95% CI = 1.06-1.38), obesity + HIV (HR = 1.24 95% CI = 1.04-1.48), and multimorbidity (HR = 1.26, 95% CI = 1.13-1.40) had poorer overall survival than women without these conditions.

CONCLUSIONS

Irrespective of the stage, multimorbidity at breast cancer diagnosis was an important prognostic factor for survival in our SABCHO cohort. The high prevalence of multimorbidity in our cohort calls for more comprehensive care to improve outcomes for South African women with breast cancer.

Для цитирования: Ayeni Oluwatosin A, Joffe Maureen, Mapanga Witness, Chen Wenlong Carl, O'Neil Daniel S, Phakathi Boitumelo, Nietz Sarah, Buccimazza Ines, Čačala Sharon, Stopforth Laura W, Jacobson Judith S, Crew Katherine D, Neugut Alfred I, Ramiah Duvern, Ruff Paul, Cubasch Herbert, Chirwa Tobias, McCormack Valerie, Micklesfield Lisa K, Norris Shane A. Multimorbidity and overall survival among women with breast cancer: results from the South African Breast Cancer and HIV Outcomes Study.. Breast cancer research : BCR. 2023. DOI: 10.1186/s13058-023-01603-w.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.